Innoviva, Inc(NASDAQ:INVA) 
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals. The company has long-acting beta2 agonist (LABA) collaboration agreement with Glaxo Group Limited to develop and commercialize once-daily products for the treatment of chronic obstructive pulmonary disease and asthma...
Website: http://www.inva.com
Founded: 1996
Full Time Employees: 5
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 17.89
H 18.03
L 17.22
C 17.72
V 989,993
10EMA 17.72
20EMA 17.72
60EMA 17.72
120EMA 17.72
250EMA 17.72